@article{f13882e2ad0b4ca99ac95e04cd1448f7,
title = "Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)",
abstract = "In the original publication, under section: Secondary end points, the sentence starting with: “KM estimated...” should read as: KM estimated median DoR was not reached (95% CI 13.9–not reached) in patients who had confirmed responses. The original publication has been corrected.",
author = "Shunichi Sugawara and Masashi Kondo and Toshihide Yokoyama and Toru Kumagai and Makoto Nishio and Koichi Goto and Kazuhiko Nakagawa and Takashi Seto and Nobuyuki Yamamoto and Kentarou Kudou and Takayuki Asato and Pingkuan Zhang and Yuichiro Ohe",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",
year = "2023",
month = may,
doi = "10.1007/s10147-022-02286-7",
language = "English",
volume = "28",
pages = "724--725",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "5",
}